Windtree Therapeutics (WINT) Earnings Date & Reports
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases... Show more
WINT is expected to report earnings to fall 2,725.00% to -1050 cents per share on May 17
Q1'23
Est.
$-10.50
Q4'24
Beat
by $0.75
Q4'22
Missed
by $2.48
Q3'22
Beat
by $0.13
Q2'22
Missed
by $0.41
The last earnings report on April 15 showed earnings per share of 40 cents, beating the estimate of -34 cents. With 85.74K shares outstanding, the current market capitalization sits at 3.95M.